Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Hair loss linked to prostate enlargement; stress and family history important factors.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Immune cells affect hair growth and could lead to new hair loss treatments.

Two gene areas linked to male pattern baldness found, more research needed.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

PRP helps hair growth in common hair loss disorder.

Androgens can both increase body hair and cause scalp hair loss.

Human hair contains more glycosaminoglycans in children than adults, and these compounds decrease with age, possibly affecting hair thickness.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Minoxidil and finasteride effectively treat hair loss.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

PRP therapy safely improves hair growth in people with hair loss.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

LLLT devices for hair loss need more research to define proper guidelines.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Removing p16INK4a from skin cells can lead to faster and more clumped growth, which might help with hair growth.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.